Health Care & Life Sciences » Pharmaceuticals | Hanmi Pharmaceutical Co. Ltd.

Hanmi Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
109,704
97,891
182,527
330,203
140,385
98,696
Total Accounts Receivable
221,447
290,508
784,927
271,571
250,331
183,994
Inventories
105,792
133,069
158,143
190,381
232,124
247,755
Other Current Assets
14,829
16,251
19,524
48,587
35,251
33,648
Total Current Assets
451,772
537,719
1,145,121
840,742
658,091
564,093
Net Property, Plant & Equipment
259,377
327,872
415,734
598,936
790,052
900,317
Total Investments and Advances
67,926
50,778
43,749
27,460
55,515
54,324
Intangible Assets
80,035
87,862
67,151
40,068
45,704
60,690
Other Assets
9,343
1,390
15,041
22,733
24,236
26,176
Total Assets
880,869
1,033,335
1,722,593
1,596,971
1,660,934
1,691,210
ST Debt & Current Portion LT Debt
127,795
46,856
103,195
171,306
278,588
Accounts Payable
38,401
52,826
56,177
50,599
46,567
Income Tax Payable
4,246
3,326
6,428
1,296
4,221
Other Current Liabilities
63,419
79,345
507,821
320,944
309,800
Total Current Liabilities
233,860
182,354
673,621
544,145
639,175
Long-Term Debt
153,105
225,357
264,231
160,915
197,654
Provision for Risks & Charges
27,634
33,473
36,807
31,121
30,759
Deferred Taxes
9,071
24,808
32,887
64,086
86,415
Other Liabilities
9
-
216
123,327
-
Total Liabilities
417,954
444,088
977,785
862,454
868,510
Common Equity (Total)
409,385
527,463
674,945
659,461
711,711
Total Shareholders' Equity
409,385
527,463
674,945
659,461
711,711
Total Equity
462,915
589,246
744,808
734,517
792,424
Liabilities & Shareholders' Equity
880,869
1,033,335
1,722,593
1,596,971
1,660,934
Accumulated Minority Interest
53,530
61,783
69,863
75,056
80,713

About Hanmi Pharmaceutical Co.

View Profile
Address
214 Muha-ro
Hwaseong GY 18536
Korea, Republic Of
Employees -
Website http://www.hanmipharm.com
Updated 07/08/2019
Hanmi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for high blood pressure, hyperlipidemia, reflux esophagitis, and cerebrovascular disease. The company was founded by Lim Sung-Gi on June 15, 1973 and is headquartered in Hwaseong-si, South Korea.